Risk of congenital heart defects in the offspring of smoking mothers: A population-based study

Journal of Pediatrics

Volumn 166, Issue 4, 2015, Pages 978-984.e2

  Sullivan, Patrick M ^a   Dervan, Leslie A ^b   Reiger, Sheridan ^c   Buddhe, Sujatha ^b   Schwartz, Stephen M ^c  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b SEATTLE CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGENESIS; AORTA COARCTATION; AORTA STENOSIS; ARTERIAL TRUNK; ARTICLE; BIRTH CERTIFICATE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; COMPARATIVE STUDY; CONGENITAL HEART MALFORMATION; CONTROLLED STUDY; DEMOGRAPHY; FALLOT TETRALOGY; FEMALE; FIRST TRIMESTER PREGNANCY; HEART ATRIUM SEPTUM DEFECT; HEART RIGHT VENTRICLE DOUBLE OUTLET; HUMAN; ICD-9; INFANT; LOW BIRTH WEIGHT; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; MATERNAL SMOKING; MITRAL VALVE STENOSIS; PHENOTYPE; PREGNANCY DIABETES MELLITUS; PREMATURITY; PRIORITY JOURNAL; PROGENY; PULMONARY ARTERY MALFORMATION; PULMONARY ARTERY STENOSIS; PULMONARY VALVE ATRESIA; PULMONARY VALVE DISEASE; RETROSPECTIVE STUDY; TRICUSPID VALVE DISEASE; ADOLESCENT; ADVERSE EFFECTS; ENVIRONMENTAL EXPOSURE; FOLLOW UP; HEALTH SURVEY; HEART DEFECTS, CONGENITAL; INCIDENCE; MOTHER; NEWBORN; PREGNANCY; PRENATAL EXPOSURE; PREVALENCE; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; SMOKING; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; FEMALE; FOLLOW-UP STUDIES; HEART DEFECTS, CONGENITAL; HUMANS; INCIDENCE; INFANT, NEWBORN; MALE; MATERNAL EXPOSURE; MOTHERS; POPULATION SURVEILLANCE; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL EXPOSURE DELAYED EFFECTS; PREVALENCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; WASHINGTON; YOUNG ADULT;

EID: 84928959347     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2014.11.042     Document Type: Article

References (40)

1. Allen HD, Driscoll DJ, Shaddy RE, Feltes TF, eds. Moss and Adams' heart disease in infants, children, and adolescents. 7th ed. Philadelphia: Lippincott Williams and Wilkins; 2008.
2. Jenkins KJ, Correa A, Feinstein JA, Botto L, Britt AE, Daniels SR, et al. Noninherited risk factors and congenital cardiovascular defects: current knowledge: A scientific statement from the American Heart Association Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation 2007;115:2995-3014.
3. Shillingford AJ, Glanzman MM, Ittenbach RF, Clancy RR, Gaynor JW, Wernovsky G. Inattention, hyperactivity, and school performance in a population of school-age children with complex congenital heart disease. Pediatrics 2008;121:e759-67.
4. Boulet SL, Grosse SD, Riehle-Colarusso T, Correa-Villasenor A. Health care costs of congenital heart defects. In: Wyszynski DF, Correa-Villasenor A, Graham TP, eds. Congenital heart defects: from origin to treatment. New York: Oxford University Press, Inc; 2010. p. 493-501.
5. Tong VT, Dietz PM, Morrow B, D'Angelo DV, Farr SL, Rockhill KM, et al. Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000-2010. MMWR Surveill Summ 2013;62:1-19.
6. Evans DR, Newcombe RG, Campbell H. Maternal smoking habits and congenital malformations: A population study. BMJ 1979;2:171-3.
7. Karatza AA, Giannakopoulos I, Dassios TG, Belavgenis G, Mantagos SP, Varvarigou AA. Periconceptional tobacco smoking and isolated congenital heart defects in the neonatal period. Int J Cardiol 2011;148: 295-9.
8. Lee LJ, Lupo PJ. Maternal smoking during pregnancy and the risk of congenital heart defects in offspring: A systematic review and metaanalysis. Pediatr Cardiol 2012;34:398-407.
9. Cedergren MI, Kallen BA. Obstetric outcome of 6,346 pregnancies with infants affected by congenital heart defects. Eur J Obstet Gynecol Reprod Biol 2006;125:211-6.
10. Kallen K. Maternal smoking and congenital heart defects. Eur J Epidemiol 1999;15:731-7.
11. Alverson CJ, Strickland MJ, Gilboa SM, Correa A. Maternal smoking and congenital heart defects in the Baltimore-Washington Infant Study. Pediatrics 2011;127:e647-53.
12. Malik S, Cleves MA, Honein MA, Romitti PA, Botto LD, Yang S, et al. Maternal smoking and congenital heart defects. Pediatrics 2008;121: e810-6.
13. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A , The National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol 2007;79:714-27.
14. Oyen N, Poulsen G, Boyd HA, Wohlfahrt J, Jensen PK, Melbye M. National time trends in congenital heart defects, Denmark, 1977-2005. Am Heart J 2009;157:467-73.
15. Hartman RJ, Rasmussen SA, Botto LD, Riehle-Colarusso T, Martin CL, Cragan JD, et al. The contribution of chromosomal abnormalities to congenital heart defects: A population-based study. Pediatr Cardiol 2011;32:1147-57.
16. Tikkanen J, Heinonen OP. Maternal exposure to chemical and physical factors during pregnancy and cardiovascular malformations in the offspring. Teratology 1991;43:591-600.
17. Hackshaw A, Rodeck C, Boniface S. Maternal smoking in pregnancy and birth defects: A systematic review based on 173,687 malformed cases and 17 million controls. Hum Reprod Update 2010;17:589-604.
18. Zdravkovic T, Genbacev O, McMaster MT, Fisher SJ. The adverse effects of maternal smoking on the human placenta: A review. Placenta 2005;26: S81-6.
19. Ahlborg G, Bodin L. Tobacco smoke exposure and pregnancy outcome among working women. Am J Epidemiol 1991;133:338-47.
20. Andres RL, Day MC. Perinatal complications associated with maternal tobacco use. Semin Neonatol 2000;5:231-41.
21. Socol ML, Manning FA, Murata Y, Druzin ML. Maternal smoking causes fetal hypoxia: experimental evidence. Am J Obstet Gynecol 1982;142: 214-8.
22. Rogers JM. Tobacco and pregnancy. Reprod Toxicol 2009;28:152-60.
23. Patterson AJ, Zhang L. Hypoxia and fetal heart development. Curr Mol Med 2010;10:653-66.
24. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000;6:109-16.
25. Barak Y, Nelson MC, Ong ES, Jones YZ, Ruiz-Lozano P, Chien KR, et al. PPAR gamma is required for placental, cardiac, and adipose tissue development. Mol Cell 1999;4:585-95.
26. Ritz B, Yu F, Fruin S, Chapa G, Shaw GM, Harris JA. Ambient air pollution and risk of birth defects in Southern California. Am J Epidemiol 2002;155:17-25.
27. Gilboa SM, Mendola P, Olshan AF, Langlois PH, Savitz DA, Loomis D, et al. Relation between ambient air quality and selected birth defects, seven county study, Texas, 1997-2000. AmJ Epidemiol 2005;162:238-52.
28. McDonald SD, Perkins SL, Jodouin CA, Walker MC. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol 2002;187:620-5.
29. Mannino DM, Mulinare J, Ford ES, Schwartz J. Tobacco smoke exposure and decreased serum and red blood cell folate levels: data from the Third National Health and Nutrition Examination Survey. Nicotine Tob Res 2003;5:357-62.
30. Rosenquist TH. Folate, homocysteine, and the cardiac neural crest. Dev Dyn 2013;242:201-18.
31. Hobbs CA, James SJ, Jernigan S, Melnyk S, Lu Y, Malik S, et al. Congenital heart defects, maternal homocysteine, smoking, and the 677 C>T polymorphism in the methylenetetrahydrofolate reductase gene: evaluating gene-environment interactions. Am J Obstet Gynecol 2006;194:218-24.
32. Hollier LM, Leveno KJ, Kelly MA, MCIntire DD, Cunningham FG. Maternal age and malformations in singleton births. Obstet Gynecol 2000;96:701-6.
33. Miller A, Riehle-Colarusso T, Siffel C, Frias JL, Correa A. Maternal age and prevalence of isolated congenital heart defects in an urban area of the United States. Am J Med Genet A 2011;155A:2137-45.
34. Ferencz C, Correa-Villasenor A, Loffredo CA, eds. Genetic and environmental risk factors of major cardiovascular malformations: The Baltimore-Washington Infant Study: 1981-1989. Armonk (NY): Futura Publishing Co; 1997.
35. Frohnert BK, Lussky RC, Alms MA, Mendelsohn NJ, Symonik DM, Falken MC. Validity of hospital discharge data for identifying infants with cardiac defects. J Perinatol 2005;25:737-42.
36. Cronck CE, Malloy ME, Pelech AN, Miller RE, Meyer SA, Cowell M, et al. Completeness of state administrative databases for surveillance of congenital heart disease. Birth Defects Res A Clin Mol Teratol 2003;67: 597-603.
37. Strickland MJ, Riehle-Colarusso TJ, Jacobs JP, Reller MD, Mahle WT, Botto LD, et al. The importance of nomenclature for congenital cardiac disease: implications for research and evaluation. Cardiol Young 2008; 18:92-100.
38. Honein MA, Paulozzi LJ, Watkins ML. Maternal smoking and birth defects: validity of birth certificate data for effect estimation. Public Health Rep 2001;116:327-35.
39. Dietz PM, Adams MM, Kendrick JS, Mathis MP. Completeness of ascertainment of prenatal smoking using birth certificates and confidential questionnaires. Am J Epidemiol 1998;148:1048-54.
40. Searles Nielsen S, Dills RL, Glass M, Mueller BA. Accuracy of prenatal smoking data from Washington State birth certificates in a population-based sample with cotinine measurements. Ann Epidemiol 2014;24:236-9.